Phase II Study of Oxaliplatin and Navelbine for Second-Line Treatment of Advanced NSCLC.

The recruitment status of this study is unknown because the information has not been verified recently.

Verified October 2005 by Integrated Community Oncology Network.
Recruitment status was Not yet recruiting

Sponsor:

Collaborator:

Sanofi

Information provided by:

Integrated Community Oncology Network

ClinicalTrials.gov Identifier:

NCT00238849

First received: October 12, 2005

Last updated: October 13, 2005

Last verified: October 2005

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is not yet open for participant recruitment.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given